Jun 05, 2020
2020 Paracetamol (Capsule, Liquid Suspension, Tablet) Industry Analysis
May 28, 2020
OrthogenRx Announces New TriVisc® Patient Programs
May 26, 2020
Global Paracetamol Market Analysis 2020-2024, Featuring Vendor Profiles of Anhui BBCA Likang Pharmaceutical Co. Ltd., Mallinckrodt Plc, Meghmani Group and Zhejiang Kangle Pharmaceutical Co. Ltd
May 22, 2020
Mayne Pharma launches BAC 300 capsules in the United States
May 11, 2020
The Global Paracetamol Market is expected to grow by $ 484.77 mn during 2020-2024 progressing at a CAGR of 8% during the forecast period
Apr 06, 2020
Perrigo Announces FDA Approval for the Store Brand Equivalent of Voltaren® Arthritis Pain
Mar 31, 2020
Cumberland Pharmaceuticals Announces Initiative to Expand Availability of Caldolor® to Help Treat High Fevers Associated With Coronavirus Infections
Mar 20, 2020
Information Update - No scientific evidence that ibuprofen worsens COVID-19 symptoms
Mar 17, 2020
Caldolor® Demonstrates Favorable Safety Profile In Newborns
Feb 28, 2020
FDA approves GSK's Advil Dual Action with Acetaminophen for over-the-counter use in the United States
Feb 28, 2020
FDA approves GSK's Advil Dual Action with Acetaminophen for over-the-counter use in the United States
Feb 27, 2020
Nuvo Pharmaceuticals® Announces Health Canada Approves Suvexx(TM) For The Acute Treatment of Migraine
Feb 27, 2020
Biohaven's NURTEC(TM) ODT (rimegepant) Receives FDA Approval for the Acute Treatment of Migraine in Adults
Feb 25, 2020
eNeura, Inc. Announces Hire of Donald Pearl as Chief Executive Officer
Feb 19, 2020
Heron Therapeutics Announces FDA Extension of Review Period for NDA for HTX-011 for the Management of Postoperative Pain
Feb 14, 2020
FDA Approves Three Drugs for Nonprescription Use Through Rx-to-OTC Switch Process
Jan 20, 2020
Crescita Signs Exclusive Distribution Agreement with FILLMED
Jan 13, 2020
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises
Jan 07, 2020
Cumberland Pharmaceuticals Announces The National Launch Of A New Caldolor Ready-To-Use Product
Jan 06, 2020
ATAI Life Sciences Partners with Neuronasal Inc. to Develop Novel Treatment for mild Traumatic Brain Injury (mTBI)